41. Cell. 2018 May 31;173(6):1398-1412.e22. doi: 10.1016/j.cell.2018.03.068. Epub2018 May 3.Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element.Cho SW(1), Xu J(1), Sun R(2), Mumbach MR(1), Carter AC(1), Chen YG(1), YostKE(1), Kim J(3), He J(1), Nevins SA(1), Chin SF(4), Caldas C(5), Liu SJ(6),Horlbeck MA(7), Lim DA(8), Weissman JS(7), Curtis C(2), Chang HY(9).Author information: (1)Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA94305, USA.(2)Departments of Medicine and Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford, CA 94305, USA.(3)Stanford Cancer Institute, Stanford, CA 94305, USA.(4)Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka ShingCentre, University of Cambridge, Cambridge CB2 0RE, UK.(5)Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka ShingCentre, University of Cambridge, Cambridge CB2 0RE, UK; Breast Cancer Program,CRUK Cambridge Cancer Centre, Cambridge University Hospitals NHS FoundationTrust, Cambridge CB2 2QQ, UK.(6)Department of Neurological Surgery, University of California, San Francisco,San Francisco, CA 94143, USA; Eli and Edythe Broad Center of RegenerationMedicine and Stem Cell Research, University of California, San Francisco, SanFrancisco, CA 94143, USA.(7)Department of Cellular and Molecular Pharmacology, University of California,San Francisco, San Francisco, CA 94143, USA; Howard Hughes Medical Institute,University of California, San Francisco, San Francisco, CA 94143, USA; CaliforniaInstitute for Quantitative Biomedical Research, University of California, SanFrancisco, San Francisco, CA 94143, USA.(8)Department of Neurological Surgery, University of California, San Francisco,San Francisco, CA 94143, USA; Eli and Edythe Broad Center of RegenerationMedicine and Stem Cell Research, University of California, San Francisco, SanFrancisco, CA 94143, USA; San Francisco Veterans Affairs Medical Center, SanFrancisco, San Francisco, CA 94121, USA.(9)Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA94305, USA. Electronic address: howchang@stanford.edu.Noncoding mutations in cancer genomes are frequent but challenging to interpret. PVT1 encodes an oncogenic lncRNA, but recurrent translocations and deletions inhuman cancers suggest alternative mechanisms. Here, we show that the PVT1promoter has a tumor-suppressor function that is independent of PVT1 lncRNA.CRISPR interference of PVT1 promoter enhances breast cancer cell competition and growth in vivo. The promoters of the PVT1 and the MYC oncogenes, located 55 kbapart on chromosome 8q24, compete for engagement with four intragenic enhancersin the PVT1 locus, thereby allowing the PVT1 promoter to regulate pause releaseof MYC transcription. PVT1 undergoes developmentally regulated monoallelicexpression, and the PVT1 promoter inhibits MYC expression only from the samechromosome via promoter competition. Cancer genome sequencing identifiesrecurrent mutations encompassing the human PVT1 promoter, and genome editingverified that PVT1 promoter mutation promotes cancer cell growth. These resultshighlight regulatory sequences of lncRNA genes as potential disease-associatedDNA elements.Copyright © 2018 Elsevier Inc. All rights reserved.DOI: 10.1016/j.cell.2018.03.068 PMCID: PMC5984165 [Available on 2019-05-31]PMID: 29731168 